Subfoveal choroidal thickness in idiopathic choroidal neovascularization
- PMID: 24793527
- DOI: 10.1016/j.ophtha.2014.01.030
Subfoveal choroidal thickness in idiopathic choroidal neovascularization
Similar articles
-
Subfoveal choroidal thickness in idiopathic choroidal neovascularization and treatment outcomes after intravitreal bevacizumab therapy.Retina. 2015 Mar;35(3):481-6. doi: 10.1097/IAE.0000000000000354. Retina. 2015. PMID: 25313710
-
Subfoveal choroidal thickness change after intravitreal ranibizumab for idiopathic choroidal neovascularization.Retina. 2014 Aug;34(8):1554-9. doi: 10.1097/IAE.0000000000000122. Retina. 2014. PMID: 24667570
-
Subfoveal choroidal thickness as a potential predictor of visual outcome and treatment response after intravitreal ranibizumab injections for typical exudative age-related macular degeneration.Am J Ophthalmol. 2014 May;157(5):1013-21. doi: 10.1016/j.ajo.2014.01.019. Epub 2014 Jan 30. Am J Ophthalmol. 2014. PMID: 24487050
-
Myopic choroidal neovascularization.Ophthalmology. 2011 Dec;118(12):2521-3. doi: 10.1016/j.ophtha.2011.07.029. Ophthalmology. 2011. PMID: 22136676 Clinical Trial. No abstract available.
-
Association between choroidal morphology and anti-vascular endothelial growth factor treatment outcome in myopic choroidal neovascularization.Invest Ophthalmol Vis Sci. 2013 Mar 1;54(3):2115-22. doi: 10.1167/iovs.12-11542. Invest Ophthalmol Vis Sci. 2013. PMID: 23462751
Cited by
-
Cytokine profiling reveals increased serum inflammatory cytokines in idiopathic choroidal neovascularization.BMC Ophthalmol. 2019 Apr 24;19(1):94. doi: 10.1186/s12886-019-1101-6. BMC Ophthalmol. 2019. PMID: 31014258 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources